prevention, diagnosis and management of COVID‐19 in the IBD patient
AH Al‐Ani, RE Prentice, CA Rentsch… - Alimentary …, 2020 - Wiley Online Library
Background The current COVID‐19 pandemic, caused by SARS‐CoV‐2, has emerged as a
public health emergency. All nations are seriously challenged as the virus spreads rapidly …
public health emergency. All nations are seriously challenged as the virus spreads rapidly …
A review of juvenile polyposis syndrome
E Chow, F Macrae - Journal of gastroenterology and …, 2005 - Wiley Online Library
Abstract Juvenile Polyposis Syndrome is an uncommon hamartomatous disorder with
significant gastrointestinal malignant potential. Mutations in SMAD4 and BMPR1A …
significant gastrointestinal malignant potential. Mutations in SMAD4 and BMPR1A …
[HTML][HTML] Celecoxib for the prevention of sporadic colorectal adenomas
MM Bertagnolli, CJ Eagle, AG Zauber… - … England Journal of …, 2006 - Mass Medical Soc
Background Studies showing that drugs that inhibit cyclooxygenase-2 (COX-2) reduce the
number of colorectal adenomas in animals and patients with familial adenomatous …
number of colorectal adenomas in animals and patients with familial adenomatous …
[HTML][HTML] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
Background Observational studies report reduced colorectal cancer in regular aspirin
consumers. Randomised controlled trials have shown reduced risk of adenomas but none …
consumers. Randomised controlled trials have shown reduced risk of adenomas but none …
[HTML][HTML] Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing
M Lorans, E Dow, FA Macrae, IM Winship… - Clinical colorectal …, 2018 - Elsevier
Colorectal cancer (CRC), one of the most common cancers, is a major public health issue
globally, especially in Westernized countries. Up to 35% of CRCs are thought to be due to …
globally, especially in Westernized countries. Up to 35% of CRCs are thought to be due to …
Crohn's disease management after intestinal resection: a randomised trial
P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie… - The Lancet, 2015 - thelancet.com
Summary Background Most patients with Crohn's disease need an intestinal resection, but a
majority will subsequently experience disease recurrence and require further surgery. This …
majority will subsequently experience disease recurrence and require further surgery. This …
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2018 - gut.bmj.com
Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now
survive both their first and subsequent cancers, resulting in a growing number of older …
survive both their first and subsequent cancers, resulting in a growing number of older …
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome …
P Møller, T Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2017 - gut.bmj.com
Objective Estimates of cancer risk and the effects of surveillance in Lynch syndrome have
been subject to bias, partly through reliance on retrospective studies. We sought to establish …
been subject to bias, partly through reliance on retrospective studies. We sought to establish …
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
The clinical classification of hereditary sequence variants identified in disease-related genes
directly affects clinical management of patients and their relatives. The International Society …
directly affects clinical management of patients and their relatives. The International Society …
[HTML][HTML] Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch
syndrome and result in different but imprecisely known cancer risks. This study aimed to …
syndrome and result in different but imprecisely known cancer risks. This study aimed to …